Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy

Breast Cancer Research and Treatment

Volumn 94, Issue 1, 2005, Pages 53-61

  Kreukels, Baudewijntje P C ^a   Schagen, Sanne B ^a   Ridderinkhof, K Richard ^b,d   Boogerd, Willem ^a,c   Hamburger, Hans L ^c   Van Dam, Frits S A M ^a,b  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c SLOTERVAART HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Adjuvant chemotherapy; Breast carcinoma; Cognitive deficits; Cyclophosphamide methotrexate and 5 fluorouracil (CMF); Information processing; Neurophysiology; Neurotoxicity; P3

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADULT; AMPLITUDE MODULATION; ARTICLE; BRAIN FUNCTION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; COGNITION; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; INFORMATION PROCESSING; PRIORITY JOURNAL; REACTION TIME; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; TREATMENT WITHDRAWAL;

ADULT; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; CYCLOPHOSPHAMIDE; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NEUROTOXICITY SYNDROMES; REACTION TIME;

EID: 26244458335     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-7093-3     Document Type: Article

References (45)

1. TA Ahles AJ Saykin CT Furstenberg B Cole LA Mott K Skalla MB Whedon S Bivens T Mitchell ER Greenberg PM Silberfarb 2002 Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma J Clin Oncol 20 485 493
2. CB Brezden KA Phillips M Abdolell T Bunston IF Tannock 2000 Cognitive function in breast cancer patients receiving adjuvant chemotherapy J Clin Oncol 18 2695 2701
3. A Minisini G Atalay A Bottomley F Puglisi M Piccart L Biganzoli 2004 What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol 5 273 282
4. SB Schagen FS van Dam MJ Muller W Boogerd J Lindeboom PF Bruning 1999 Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma Cancer 85 640 650
5. FS Van Dam SB Schagen MJ Muller W Boogerd E vd Wall ME Droogleever Fortuyn S Rodenhuis 1998 Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy J Natl Cancer Inst 90 210 218
6. JS Wefel R Lenzi RL Theriault RN Davis CA Meyers 2004 The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial Cancer 100 2292 2299
7. E Chu A Mota M Fogarasi 2001 Antimetabolites (Section 5). Pharmacology of cancer chemotherapy (Chapter 19) VT DeVita S Hellman SA Rosenberg Cancer. Principles & Practice of Oncology Lippincott Williams & Wilkins Philadelphia 388 415
8. MK Tuxen SW Hansen 1994 Neurotoxicity secondary to antineoplastic drugs Cancer Treat Rev 20 191 214
9. AJ Saykin TA Ahles BC McDonald 2003 Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives Semin Clin Neuropsychiatr 8 201 216
10. SB Schagen HL Hamburger MJ Muller W Boogerd FS Van Dam 2001 Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function J Neurooncol 51 159 165
11. EJ Jonkman AC van Huffelen G Pfurtscheller 1986 Quantitative EEG and cerebral ischemia FH Lopes da Silva W Storm van Leeuwen A Remond Handbook of Electroencephalography and Clinical Neurophysiology Elsevier Amsterdam 205 237
12. R Halliday H Naylor D Brandeis E Callaway L Yano K Herzig 1994 The effect of D-amphetamine, clonidine, and yohimbine on human information processing Psychophysiology 31 331 337
13. J Ruijter MB de Ruiter J Snel MM Lorist 2000 The influence of caffeine on spatial-selective attention: an event-related potential study Clin Neurophysiol 111 2223 2233
14. FT Smulders JL Kenemans WF Schmidt A Kok 1999 Effects of task complexity in young and old adults: reaction time and P300 latency are not always dissociated Psychophysiology 36 118 125
15. MW Van der Molen TR Bashore R Halliday E Callaway 1991 Chronopsychophysiology: mental chronometry augmented by psychophysiological time markers JR Jennings MGH Coles Handbook of Cognitive Psychophysiology: Central and Autonomic Nervous System Approaches John Wiley & Sons Ltd Chichester 9 178
16. E Donchin MGH Coles 1988 Is the P300 component a manifestation of context updating Behav Brain Sci 11 357 374
17. R. Jr. Johnson 1988 The amplitude of the P300 component of the event-related potential: review and synthesis Adv psychophysiol 3 69 137
18. A Kok 2001 On the utility of P3 amplitude as a measure of processing capacity Psychophysiology 38 557 577
19. RJ Barry SJ Johnstone AR Clarke 2003 A review of electrophysiology in attention-deficit/hyperactivity disorder: II. Event-related potentials Clin Neurophysiol 114 184 198
20. O van der Stelt J Frye JA Lieberman A Belger 2004 Impaired P3 generation reflects high-level and progressive neurocognitive dysfunction in schizophrenia Arch Gen Psychiatr 61 237 248
21. H Saito H Yamazaki H Matsuoka K Matsumoto Y Numachi S Yoshida T Ueno M Sato 2001 Visual event-related potential in mild dementia of the Alzheimer's type Psychiatr Clin Neurosci 55 365 371
22. S Sternberg 1969 The discovery of processing stages: extensions of Donders' method Acta Psychol 30 276 315
23. AF Sanders 1983 Towards a model of stress and human performance Acta Psychol (Amst) 53 61 97
24. AF Sanders 1990 Issues and trends in the debate on dicrete vs. continuous processing of information Acta Psychol 74 123 167
25. A Kok 1997 Event-related-potential (ERP) reflections of mental resources: a review and synthesis Biol Psychol 45 19 56
26. LR Derogatis RS Lipman K Rickels EH Uhlenhuth L Covi 1974 The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions Mod Probl Pharmacopsychiatr 7 79 110
27. PT Hesbacher K Rickels RJ Morris H Newman H Rosenfeld 1980 Psychiatric illness in family practice J Clin Psychiatr 41 6 10
28. RL Hough JA Landsverk GF Jacobsen 1990 The use of psychiatric screening scales to detect depression in primary care patients CC Attkinsson JM Zich Depression in Primary Care: Screening and Detection Routledge New York & London
29. FDM Wald GJ Mellenbergh 1990 De verkorte versie van de Nederlandse vertaling van de Profile of Mood States (POMS) Nederlands Tijdschrift voor de Psychologie 45 86 90
30. WF Regine FA Schmitt CB Scott C Dearth RA Patchell RC Nichols Jr. EM Gore RL III Franklin JH Suh MP Mehta 2004 Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018 Int J Radiat Oncol Biol Phys 58 1346 1352
31. N de Jong MJ Candel HC Schouten HH Abu-Saad AM Courtens 2004 Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy Ann Oncol 15 896 905
32. EMA Smets B Garssen B Bonke 1995 Het meten van vermoeidheid met de Multidimensionele Vermoeidheids Index (MVI-20): Een handleiding Medische Psychologie, Academisch Medisch Centrum Amsterdam, The Netherlands
33. E Donchin 1981 Surprise! Surprise? Psychophysiology 18 493 513
34. CW Berridge BD Waterhouse 2003 The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes Brain Res Brain Res Rev 42 33 84
35. Nieuwenhuis S, Aston-Jones G, Cohen JD: Decision making, the P3, and the Locus Coeruleus-Norepinephrine System. Psychol Bull, in press
36. J Keller BD Hicks GA Miller 2000 Psychophysiology in the study of psychopathology JT Cacioppo LG Tassinary GG Berntson Handbook of Psychophysiology 2 Cambridge University Press Cambridge 719 750
37. SB Schagen MJ Muller W Boogerd FS Van Dam 2002 Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective Clin Breast Cancer 3 Suppl 3 S100 S108
38. Boogerd W: Neurological complications of chemotherapy. In: Vinken and Bruyn (ed) Handbook of Clinical Neurology: Intoxications of the Nervous System Part II. Elsevier Science, 1995, pp 527-546
39. WA Bleyer 1981 Neurologic sequelae of methotrexate and ionizing radiation: a new classification Cancer Treat Rep 65 Suppl 1 89 98
40. A Paganini-Hill LJ Clark 2000 Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen Breast Cancer Res Treat 64 165 176
41. SA Castellon PA Ganz JE Bower L Petersen L Abraham GA Greendale 2004 Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen J Clin Exp Neuropsychol 26 955 969
42. JL Eberling C Wu R Tong-Turnbeaugh WJ Jagust 2004 Estrogen- and tamoxifen-associated effects on brain structure and function Neuroimage 21 364 371
43. T Ernst L Chang D Cooray C Salvador J Jovicich I Walot K Boone R Chlebowski 2002 The effects of tamoxifen and estrogen on brain metabolism in elderly women J Natl Cancer Inst 94 592 597
44. C Falo A Moreno E Benito B Lloveras M Varela JM Serra L Prieto D Azpeitia A Escobedo 2005 Primary chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil in operable breast carcinoma Cancer 103 657 663
45. SB Schagen MJ Muller W Boogerd RM Rosenbrand D van Rhijn S Rodenhuis FS Van Dam 2002 Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients Ann Oncol 13 1387 1397